Sekisui Diagnostics Respiratory Test Kit OSOM® Ultra Plus Infectious Disease Immunoassay Influenza A + B Nasal Swab / Nasopharyngeal Swab Sample 25 Tests CLIA Waived for Swab - Case of 18 - 1032-CS
Sekisui Diagnostics Respiratory Test Kit OSOM® Ultra Plus Infectious Disease Immunoassay Influenza A + B Nasal Swab / Nasopharyngeal Swab Sample 25 Tests CLIA Waived for Swab - Case of 18 - 1032-CS
Regular price
$8,520.99
Sale price
$8,520.99
Regular price
Unit price
per
Shipping calculated at checkout.
50 In stock
Estimated deliver:
Flat-Rate Shipping from $8.25
Sekisui Diagnostics Respiratory Test Kit OSOM® Ultra Plus Infectious Disease Immunoassay Influenz...
| Item Id | 1173369 |
| MF Id# | 1032 |
| Brand | OSOM® Ultra Plus |
| Manufacturer | Sekisui Diagnostics |
| Country of Origin | United States |
| Application | Respiratory Test Kit |
| CLIA Classification | CLIA Waived for Swab |
| CLIA Classified | CLIA Waived Sample Dependent |
| Contents 1 | (25) Test Sticks, (25) Sterile Nasal Swabs, (25) Extraction Buffer Vials, (1) Influenza A+ Control Swab, (1) Influenza B+ Control Swab, IFU, QRG, (1) Workstation |
| Number of Tests | 25 Tests |
| Product Dating | McKesson Acceptable Dating: we will ship >= 90 days |
| Purchase Program Type | Standard Purchase |
| Reading Type | Visual Read |
| Sample Type | Nasal Swab / Nasopharyngeal Swab Sample |
| Specialty | Immunoassay |
| Test Format | Dipstick Format |
| Test Name | Influenza A + B |
| Test Type | Infectious Disease Immunoassay |
| Time to Results | 10 Minute Results |
| UNSPSC Code | 41116144 |
Features
- The OSOM Ultra Plus Flu A&B Test is an in vitro rapid diagnostic immunochromatography assay intended for the qualitative detection of influenza type A and B nucleoprotein antigens directly from nasal and nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection
- Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples
- Accurate, differentiated interpretation of results in 10 minutes to test and treat patients in one office visit
- Meets the Influenza reclassification requirements for rapid antigen tests